Solvotrin Therapeutics

Solvotrin Therapeutics is a pharmaceutical company that focuses on improving and enhancing existing medications.

Total raised

€6.7M

€6,700,000

Funding rounds

Investors

distinct backers

Active since

2020-11

latest 2020-11

Funding by year

EUR raised per year

Medium confidence

Raise-next likelihood12

base rate 30% for Other

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

1 rounds

Date	Stage	Amount	Investors
2020-11-03	Other	€6.7M	—	View deal →

same sector or country